UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 62.50
+0.50 (0.81%)
Jul 22, 2025, 1:03 PM CST
UnicoCell Biomed Revenue
UnicoCell Biomed had revenue of 9.85M TWD in the quarter ending March 31, 2025, with 269.18% growth. This brings the company's revenue in the last twelve months to 39.06M, up 66.95% year-over-year. In the year 2024, UnicoCell Biomed had annual revenue of 31.88M with 29.66% growth.
Revenue (ttm)
39.06M
Revenue Growth
+66.95%
P/S Ratio
97.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.79B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| TaiMed Biologics | 607.46M |